Epilepsia

Volver al artículo.

Referencias para el artículo

  1. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clinic Proc 1921;2:307–8.
  2. Prasad AN, Stafstrom CF, Holmes GL. Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids. Epilepsia 1996;37:S81–S95 [review].
  3. Vining EP, Freemen JM, Ballaban-Gil K, et al. A multicenter study of the efficacy of the ketogenic diet. Arch Neurol 1998;55:1433–7.
  4. Freeman JM, Vining EP, Pillas DJ, et al. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998;102:1358–63.
  5. Neelam GK, Koehler AN, McGhee B, et al. The ketogenic diet in refractory epilepsy: the experience of Children’s Hospital of Pittsburgh. Clinical Pediatrics 2000;39:153–9.
  6. Barborka CJ. Results of treatment by ketogenic diet in one hundred cases of epilepsy in adults. Assoc Res Nerv Ment Dis 1929;7:638–58.
  7. Ballaban-Gil K, Callahan CM, O’Dell C, et al. The ketogenic diet in the treatment of intractable epilepsy in adults. Epilepsy 1996;37:92 [abstract].
  8. Ballaban-Gil K, Callahan CM, O’Dell C, et al. Complications of the ketogenic diet. Epilepsia 1998;39:744–8.
  9. Prasad AN, Stafstrom CF, Holmes GL. Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids. Epilepsia 1996;37:S81–95 [review].
  10. Barron TF, Hunt SL. A review of the newer antiepileptic drugs and the ketogenic diet. Clin Pediatr (Phila) 1997;36:513–21.
  11. Freeman JM, Kelly MT, Freeman JB. The epilepsy diet treatment. New York, NY: Demos, 1994.
  12. Carroll J, Koenigsberger D. The ketogenic diet: a practical guide for caregivers. J Am Diet Assoc 1998;98:316–21.
  13. http://www-leland.stanford.edu/group/ketodiet
  14. Stevens H. Allergy and epilepsy. Epilepsia 1965;6:205–16 [review].
  15. Campbell M. Neurologic manifestations of allergic disease. Ann Allergy 1973;31:485–98 [review].
  16. Crayton JW, Stone T, Stein G. Epilepsy precipitated by food sensitivity: report of a case with double-blind placebo-controlled assessment. Clin Electroencephalogr 1981;12:192–8.
  17. Cunningham AS. Allergy, immunodeficiency and epilepsy. Lancet 1975;11:975 [letter].
  18. Egger J, Carter CM, Soothill JF, Wilson J. Oligoantigenic diet treatment of children with epilepsy and migraine. J Pediatr 1989;114:51–8.
  19. Van Someren V, Robinson RO, McArdle B, Sturgeon N. Restricted diets for treatment of migraine. J Pediatr 1990;117:509–10 [letter].
  20. Crayton JW, Stone T, Stein G. Epilepsy precipitated by food sensitivity: report of a case with double-blind placebo-controlled assessment. Clin Electroencephalogr 1981;12:192–8.
  21. Ogunmekan AO, Hwang PA. A randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children. Epilepsia 1989;30:84–9.
  22. Hom AC, Weaver RC, Aldersen JJ. Efficacy of D-alpha tocopherol acetate as adjunctive antiepileptic agent in patients with refractory epilepsy and profound developmental disability. A prospective, randomized, double-blind, placebo-controlled trial. Epilepsia 1991;32(suppl 3):63 [abstract].
  23. Sullivan C, Capaldi N, Mack G, Buchanan N. Seizures and natural vitamin E. Med J Aust 1990;152:613–4 [letter].
  24. Tupeev IR, Kryzhanovskii GN, Nikushkin EV, et al. The antioxidant system in the dynamic combined treatment of epilepsy patients with traditional anticonvulsant preparations and an antioxidant—alpha-tocopherol. Biull Eksp Biol Med 1993;116:362–4 [in Russian].
  25. Raju GB, Behari M, Prasad K, Ahuja GK. Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy. Epilepsia 1994;35:368–72.
  26. Gibberd FB, Nicholls A, Wright MG. The influence of folic acid on the frequency of epileptic attacks. Eur J Clin Pharmacol 1981;19:57–60.
  27. Guidolin L, Vignoli A, Canger R. Worsening in seizure frequency and severity in relation to folic acid administration. Eur J Neurol 1998;5:301–3.
  28. Lewis DP, Van Dyke DC, Willhite LA. Phenytoin-folic acid interaction. Ann Pharmacother 1995;29:726–35 [review].
  29. Berg MJ, Rivey MP, Vern BA, et al. Phenytoin and folic acid: individualized drug-drug interaction. Ther Drug Monit 1983;5:395–9.
  30. Reynolds EH. Effects of folic acid on the mental state and fit frequency of drug treated epileptic patients. Lancet 1967;1:1086.
  31. Eros E, Geher P, Gomor B, et al. Epileptogenic activity of folic acid after drug induces SLE (folic acid and epilepsy). Eur J Obstet Gynecol Reprod Biol 1998;80:75–8.
  32. Ueda S, Shirakawa T, Nakazawa Y, et al. Epilepsy and folic acid. Folia Psychiatr Neurol Jpn 1977;31:327–37.
  33. Bankier A, Turner M, Hopkins IJ. Pyridoxine dependent seizures—a wider clinical spectrum. Arch Dis Child 1983;58:415–8.
  34. Baxter P, Griffiths P, Kelly T, et al. Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Develop Med Child Neurol 1996;38:998–1006.
  35. Jiao FY, Gao DY, Takuma Y, et al. Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children. Pediatr Neurol 1997;17:54–7.
  36. Goutieres F, Aicardi J. Atypical presentation of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol 1985;17:117–20.
  37. Durelli L, Mutani R. The current status of taurine in epilepsy. Clin Neuropharmacol 1983;6:37–48.
  38. Vaddadi KS. The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia. Prostaglandins Med 1981;6:375–9.
  39. Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002;43:103–104.
  40. Fauteck J, Schmidt H, Lerchl A, et al. Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol Signals Recept 1999;8:105–10.
  41. Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing 2001;30:523–5.
  42. Yarnell EY, Abascal K. An herbal formula for treating intractable epilepsy: a review of the literature. Alt Compl Ther 2000;6:203–6 [review].
  43. Narita Y, Satowa H, Kokubu T, et al. Treatment of epileptic patients with the Chinese herbal medicine “saiko-keishi-to” (SK). IRCS Med Sci 1982;10:88–9.
  44. Nagakubo S, Niwa S-I, Kumagai N, et al. Effects of TJ-960 on Sternberg’s paradigm results in epileptic patients. Jpn J Psych Neur 1993;47:609–19.